BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38679972)

  • 21. Correlations between state anxiety and quality of life in metastatic breast cancer patients.
    Dragomir BI; Fodoreanu L
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(3):610-5. PubMed ID: 24502024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biologically based therapies are commonly self-prescribed by Brazilian women for the treatment of advanced breast cancer or its symptoms.
    Alfano AC; Paiva CE; Rugno FC; da Silva RH; Paiva BS
    Support Care Cancer; 2014 May; 22(5):1303-11. PubMed ID: 24337764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating Relationship between Pre- and Post- Chemotherapy Cognitive Performance with Levels of Depression and Anxiety in Breast Cancer Patients: A Cross-Sectional Study.
    Hormozi M; Hashemi SM; Shahraki S
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3831-3837. PubMed ID: 31870129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anxiety, depression and defense mechanisms associated with treatment decisional preferences and quality of life in non-metastatic breast cancer: a 1-year prospective study.
    Hyphantis T; Almyroudi A; Paika V; Degner LF; Carvalho AF; Pavlidis N
    Psychooncology; 2013 Nov; 22(11):2470-7. PubMed ID: 23712915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the performance of four staging systems in determining the prognosis of breast cancer among women undergoing neoadjuvant chemotherapy.
    Soares ICS; Bello MA; Bergmann A; Thuler LCS
    Breast Cancer Res Treat; 2021 Jun; 187(2):547-555. PubMed ID: 33417086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial.
    Park YH; Kim TY; Kim GM; Kang SY; Park IH; Kim JH; Lee KE; Ahn HK; Lee MH; Kim HJ; Kim HJ; Lee JI; Koh SJ; Kim JY; Lee KH; Sohn J; Kim SB; Ahn JS; Im YH; Jung KH; Im SA;
    Lancet Oncol; 2019 Dec; 20(12):1750-1759. PubMed ID: 31668850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast Cancer Quality of Life and Health-state Utility at a Brazilian Reference Public Cancer Center.
    Guerra RL; Dos Reis NB; Corrêa FM; Fernandes MM; Ribeiro Alves Fernandes R; Cancela MC; Araújo RM; Crocamo S; Santos M; De Almeida LM
    Expert Rev Pharmacoecon Outcomes Res; 2020 Apr; 20(2):185-191. PubMed ID: 31106611
    [No Abstract]   [Full Text] [Related]  

  • 28. Anxiety and coping in women with breast cancer in chemotherapy.
    Silva AVD; Zandonade E; Amorim MHC
    Rev Lat Am Enfermagem; 2017 Jun; 25():e2891. PubMed ID: 28591299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticipatory anxiety in women receiving chemotherapy for breast cancer.
    Jacobsen PB; Bovbjerg DH; Redd WH
    Health Psychol; 1993 Nov; 12(6):469-75. PubMed ID: 8293730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy.
    Rier HN; Jager A; Sleijfer S; van Rosmalen J; Kock MCJM; Levin MD
    Breast; 2017 Feb; 31():9-15. PubMed ID: 27810702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes and predictors of unmet supportive care needs in Taiwanese women with newly diagnosed breast cancer.
    Liao MN; Chen SC; Chen SC; Lin YC; Hsu YH; Hung HC; Wang CH; Chen MF; Jane SW
    Oncol Nurs Forum; 2012 Sep; 39(5):E380-9. PubMed ID: 22940517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bridging the Age Gap in breast cancer: Impact of chemotherapy on quality of life in older women with early breast cancer.
    Battisti NML; Reed MWR; Herbert E; Morgan JL; Collins KA; Ward SE; Holmes GR; Bradburn M; Walters SJ; Burton M; Lifford K; Edwards A; Robinson TG; Martin C; Chater T; Pemberton KJ; Shrestha A; Brennan A; Cheung KL; Todd A; Audisio RA; Wright J; Simcock R; Green T; Revell D; Gath J; Horgan K; Holcombe C; Winter MC; Naik J; Parmeshwar R; Gosney MA; Hatton MQ; Thompson AM; Wyld L; Ring A;
    Eur J Cancer; 2021 Feb; 144():269-280. PubMed ID: 33373871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study.
    Wallington M; Saxon EB; Bomb M; Smittenaar R; Wickenden M; McPhail S; Rashbass J; Chao D; Dewar J; Talbot D; Peake M; Perren T; Wilson C; Dodwell D
    Lancet Oncol; 2016 Sep; 17(9):1203-16. PubMed ID: 27599138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic overview of chemotherapy effects in breast cancer.
    Bergh J; Jönsson PE; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):253-81. PubMed ID: 11441936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast Cancer Patients' Preferences for Truth Versus Hope Are Dynamic and Change During Late Lines of Palliative Chemotherapy.
    Bergqvist J; Strang P
    J Pain Symptom Manage; 2019 Apr; 57(4):746-752. PubMed ID: 30639732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer.
    Kim JW; Kim JG; Kang BW; Chung IJ; Hong YS; Kim TY; Song HS; Lee KH; Zang DY; Ko YH; Song EK; Baek JH; Koo DH; Oh SY; Cho H; Lee KW
    Cancer Res Treat; 2019 Jan; 51(1):223-239. PubMed ID: 30584995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect of Relaxation Techniques on Anxiety, Fatigue and Sleep Quality of Parents of Children with Leukemia under Chemotherapy in South East Iran.
    Pouraboli B; Poodineh Z; Jahani Y
    Asian Pac J Cancer Prev; 2019 Oct; 20(10):2903-2908. PubMed ID: 31653133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trait anxiety and anticipatory immune reactions in women receiving adjuvant chemotherapy for breast cancer.
    Fredrikson M; Fürst CJ; Lekander M; Rotstein S; Blomgren H
    Brain Behav Immun; 1993 Mar; 7(1):79-90. PubMed ID: 8471800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy analysis of chemotherapy and endocrine therapy combined with targeted drugs after progression on cyclin-dependent kinase 4/6 inhibitor treatment in hormone receptor positive/human epidermal growth factor receptor 2-low metastatic breast cancer].
    Liu B; Yuan Y; Li F; Li JB; Bian L; Wang T; Zhang SH; Jiang ZF
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(17):1507-1513. PubMed ID: 38706058
    [No Abstract]   [Full Text] [Related]  

  • 40. [Palliative chemotherapy for metastatic breast cancer with capecitabine].
    Inaba T; Kashiwaba M; Takeda Y; Komatsu H; Tomisawa Y; Takiyama I; Wakabayashi G
    Gan To Kagaku Ryoho; 2009 May; 36(5):769-72. PubMed ID: 19461175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.